You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Litigation Details for Arbutus Biopharma Corporation v. Moderna, Inc. (D. Del. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Arbutus Biopharma Corporation v. Moderna, Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Try a Trial .
Biologic Drugs cited in Arbutus Biopharma Corporation v. Moderna, Inc.
The biologic drug covered by the patents cited in this case is ⤷  Try a Trial .

Details for Arbutus Biopharma Corporation v. Moderna, Inc. (D. Del. 2022)

Date Filed Document No. Description Snippet Link To Document
2022-02-28 1 Complaint them. The Asserted Patents are among them: a. U.S. Patent No. 8,058,069, “Lipid Formulations…deliver nucleic acid-based medicines: U.S. Patent Nos. 8,058,069 (Exhibit A), 8,492,359 (Exhibit B), 8,822,668… COUNT 1: INFRINGEMENT OF U.S. PATENT NO. 8,058,069 65. Paragraphs 1 through 64…Arbutus’s U.S. Patent No. 9,404,127 (“the ’127 Patent”), which, like the Asserted Patents, is directed …attempted to invalidate several of the patents before the United States Patent Case 1:22-cv-00252-MSG Document External link to document
2023-08-29 129 Claim Construction Chart the six patents that Plaintiffs have asserted Defendants infringe: U.S. Patent Nos. 8,058,069 (the “’…Petition for Inter Partes Review of U.S. Patent No. 8,058,069, IPR2019-00554 (Jan. 9, 2019) Petitioner…Petition for Inter Partes Review of U.S. Patent No. 8,058,069, IPR2019-00554, Exhibit 1008 (Jan. 2, 2019…Petition for Inter Partes Review of U.S. Patent No. 8,058,069, IPR2019-00554 (Jan. 9, 2019) Petitioner…Petition for Inter Partes Review of U.S. Patent No. 8,058,069, IPR2019-00554, Exhibit 1008, (Jan. 2, 2019 External link to document
2023-09-27 133 COUNT 1: INFRINGEMENT OF U.S. PATENT NO. 8,058,069 65. Paragraphs 1 through …attempted to invalidate several of the patents before the United States Patent Case Case 1:22-cv-00252-…Arbutus’s patented technology, including the technology described and claimed in the Asserted Patents. Moderna…The United States Patent and Trademark Office duly and legally issued the ’069 Patent to one of Arbutus…incorporating Arbutus’s patented LNP delivery technology covered by the ’069 Patent, without authority or External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.